Table 4. Multiple comparisons between each of two subgroups of UM patients.
Markers1 | A | B | C | D | E | F | ||||||
MW (Da) | 1467 | 1207.56 | 1741.61 | 2024.2 | 4054.88 | 4117.41 | ||||||
Normal mean | 455.61 | 232.38 | 12.00 | 12.77 | 34.13 | 33.17 | ||||||
Mean intensity of UM I | 87.8 | 67.3 | 43.4 | 32.6 | 87.1 | 61 | ||||||
Mean intensity of UM II | 45.4 | 46.4 | 36.5 | 30.5 | 113.1 | 72.6 | ||||||
Mean intensity of UM III | 433 | 178.4 | 17 | 14.4 | 29.7 | 30.1 | ||||||
F value | 33.775 | 27.529 | 13.919 | 6.052 | 24.934 | 27.615 | ||||||
P value | <0.001 | <0.001 | <0.001 | 0.007 | <0.001 | <0.001 | ||||||
P value of I vs II | 0.419 | 0.284 | 0.199 | 0.721 | 0.04 | 0.059 | ||||||
P value of II vs III | <0.001 | <0.001 | 0.001 | 0.009 | <0.001 | <0.001 | ||||||
P value of I vs III |
<0.001 |
<0.001 |
<0.001 |
0.004 |
<0.001 |
<0.001 |
||||||
Marker1 |
H |
I |
J |
K |
L |
M |
N |
|||||
MW (Da) | 4964.57 | 1351.66 | 1897.62 | 3263.52 | 1264.62 | 1520.56 | 3192.67 | |||||
Normal mean | 25.8 | 81.6 | 17.6 | 296.9 | 66.2 | 30.8 | 160.9 | |||||
Mean intensity of UM I | 75.3 | 29.6 | 77 | 161.4 | 28 | 18.3 | 82.6 | |||||
Mean intensity of UM II | 70 | 17.5 | 62.6 | 161 | 23.5 | 16.2 | 92.2 | |||||
Mean intensity of UM III | 20.1 | 94.9 | 24.1 | 243 | 69.1 | 31.1 | 126.6 | |||||
F value | 10.994 | 14.718 | 7.001 | 7.901 | 20.113 | 14.897 | 5.821 | |||||
P value | <0.001 | <0.001 | 0.006 | 0.002 | <0.001 | <0.001 | 0.008 | |||||
P value of I vs II | 0.682 | 0.436 | 0.337 | 0.988 | 0.573 | 0.484 | 0.488 | |||||
P value of II vs III | 0.001 | <0.001 | 0.017 | 0.002 | <0.001 | <0.001 | 0.017 | |||||
P value of I vs III | <0.001 | <0.001 | 0.002 | 0.002 | <0.001 | <0.001 | 0.003 |
UM I, II and III mean refer to the three subgroups of UM patients at three different time points respectively. I: Pre-operative; II: Post-operative 1mo; III: Post-operative 6mo. F value corresponds to the fixed factor of the grouping in univariate analysis of variance. P value below 0.05 was regarded as significant. The following three P values were generated by multiple comparisons between each of two subgroups of UM patients and were regarded as significant if <0.05. 1Peptide peaks of marker G (MW 4173.61 Da) was not detected in sera of UM II patients and multiple camparisons were not performed.